# Moderna, Inc.: Form 8-K, filed Mar 5, 2026

- Company: [Moderna, Inc.](/companies/mrna.md) (CIK 1682852)
- Form: 8-K
- Filed: 2026-03-05
- Accepted by EDGAR: Mar 4, 2026, 20:20 ET
- Period: 2026-03-03
- Accession: 0001682852-26-000047
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1682852/000168285226000047/mrna-20260303.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1682852/000168285226000047/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1682852/000168285226000047/mrna-20260303.htm

Filed Mar 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001682852-26-000047. Last ingested by Listed: Nov 14, 2026, 18:43 ET. No prices; not investment advice.
